Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M
Carbon Biosciences, a biotech company developing parvovirus-derived gene therapies, has launched with $38M of financing led by Agent Capital.
Source: labiotech.eu
Johnf Engelhardt News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Johnf Engelhardt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Johnf Engelhardt Today - Breaking & Trending Today
Carbon Biosciences Launches with $38 Million Series A Financing to Advance Novel Gene Therapy Platform and Pipeline
BOSTON--(BUSINESS WIRE)--Jun 21, 2022--
Source: kulr8.com
Carbon Biosciences Raises $38M in Series A Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com